Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
20/08/2025
Sweden's central bank governor Tetden: We believe that core inflation is moving towards 2.0%. Whether we will lower interest rates in the future is still uncertain, but there is certainly a possibility.
Latest
1 m ago
Simola International: The net profit in the first half of 2025 after adjustment was 737 million yuan, a year-on-year decrease of 2.1%.
2 m ago
Chilean chemical and mining company's revenue in the first half of the year was $2.08 billion, with EBITDA at $658.1 million.
2 m ago
Simao International (06969.HK) will distribute a mid-term dividend of HKD 0.2 per share on September 25th.
2 m ago
Market news: Intel is in talks with other major investors regarding financing matters.
4 m ago
In the early trading on Wednesday, the stock price of Celldex Therapeutics (CLDX) plunged by 9.5% as its drug Barzolvolimab failed to improve symptoms of Eosinophilic Esophagitis (EoE) despite reaching the main endpoint in its phase II trial.
See all latest